Author

J. Munson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:imaging· 1

Frequent Co-Authors

K. M. Tate· 2 shared R. C. Cornelison· 2 shared A. L. Berr· 1 shared A. Mathew· 1 shared A. Mills· 1 shared A. Petrosky· 1 shared A. R. Harris· 1 shared B. J. Horton· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

K. M. Tate

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Demonstration of chemotherapeutic mediated lymphatic changes in meningeal lymphatics in vitro, ex vivo, and in vivo

L. M. Roberts, J. H. Hammel, F. Azar, T.-Y. Feng, J. J. Cunningham, M. R. Rutkowski, J. Munson

This study demonstrates that systemic chemotherapy can disrupt meningeal lymphatics, with differential effects observed between platinum and taxane chemotherapies.

bioRxiv · Jan 6, 2024 · PreprintBioengineering

Platinum chemotherapy induces lymphangiogenesis in cancerous and healthy tissues that can be prevented with adjuvant anti-VEGFR3 therapy

A. R. Harris, S. Esparza, M. S. Azimi, R. Cornelison, F. N. Azar, D. C. Llaneza, M. Belanger, A. Mathew, S. Tkachenko, M. J. Perez, C. Buchta Rosean, R. Bostic, R. C. Cornelison, K. M. Tate, S. M. Peirce-Cottler, , J. Munson

bioRxiv · Oct 8, 2021Cancer Biology

A patient-designed tissue-engineered model of the infiltrative glioblastoma microenvironment

R. C. Cornelison, J. X. Yuan, K. M. Tate, A. Petrosky, G. F. Beeghly, M. Bloomfield, S. R. Schwager, A. L. Berr, D. Cimini, F. F. Bafakih, J. W. Mandell, B. W. Purow, B. J. Horton, J. Munson

This study develops a patient-derived 3D tissue-engineered model of glioblastoma to assess invasion, proliferation, and stemness in response to fluid flow and glial interactions, finding CD71 expression better predicts drug efficacy than viability.

bioRxiv · Oct 2, 2020Bioengineering